Arquivamento definitivo - Art. 33 da LPI
#11.1.1
04/04/2023
RPI 2726
Application data
Number
112021006366Type
Filing
Publication
PCT
IB2019058651 The application was abandoned: examination was not requested within the 36 months following the 10/10/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 04/04/2023. We update with every new RPI gazette, published weekly.
Applicants
NOVARTIS AG
CH
Inventors
D. J. (pessoa física)
US
J. S. (pessoa física)
CH
IPC Classification
Priority claims
US
62/744,153 · 10/11/2018
Abstract
USO DE UM AGONISTA INVERSO H3R PARA O TRATAMENTO DE SONOLÊNCIA DIURNA EXCESSIVA ASSOCIADA À DOENÇA DE PARKINSON (DP). A presente invenção refere-se ao uso do Composto (I), conforme definido no presente documento, ou sal farmaceuticamente aceitável do mesmo, no tratamento da sonolência diurna excessiva associada à doença de Parkinson.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
04/04/2023
RPI 2726
#11.1
01/17/2023
RPI 2715
#1.3
07/06/2021
RPI 2635
#1.1
04/13/2021
RPI 2623
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.